Magid and Co

Magid and Co focuses on providing data and analysis related to Series A and Series B funding activities worldwide (excluding China), targeting non-therapeutics sectors with a raised amount over $5M. It includes deal trends, investor behaviors, and insights for founders navigating the early-stage funding market.

Early-stage funding Series A and B investment trends Global startup ecosystem excluding China Investment strategies for startups Non-therapeutics sectors funding Investor and founder advice Market dynamics and deal volumes

The hottest Substack posts of Magid and Co

And their main takeaways

Series A activity: Week of November 20, 2023

0 implied HN points • 27 Nov 23
💰 Finance
  1. The post shares data on Series A deals done in the last week.
  2. The summary stats focus on Series A deals worldwide (excluding China) with raised amounts over $5M, not in therapeutics industry.
  3. Readers can subscribe for free to receive new posts and support the author's work.

Series A activity: Week of December 4, 2023

0 implied HN points • 11 Dec 23
💼 Business Venture Capital
  1. The post provides data on Series A deals done in the last week
  2. The focus is on Series A deals worldwide (excluding China) where amount raised is over $5M and not on therapeutics
  3. Readers can subscribe for free to receive new posts and support the author's work
Get a weekly roundup of the best Substack posts, by hacker news affinity:

Series B Activity: November 2023

0 implied HN points • 07 Dec 23
💰 Finance Investing Funding Deals
  1. In November, only 4 out of 48 Series B deals had traditional VCs as lead investors, a low ratio.
  2. Despite Thanksgiving, deal volume increased by 20% compared to October in Series B activity.
  3. Total deal value went up by approximately $100 million from $1.79 billion to $1.88 billion in November.